European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S. investment. The $200 billion pharma company intends to invest ...

Headquartered in Basel, Novartis (NVS) is a Medical stock that has seen a price change of 12.64% so far this year. The drugmaker is currently shelling out a dividend of $2.52 per share ...

Shares in Swiss drugmaker Novartis (NVS) were looking perkier today as it set out plans to invest $23 billion in U.S. manufacturing to beat the tariffs threat against the industry. Discover ...

The Navodaya Vidyalaya Samiti (NVS) has announced the Jawahar Navodaya Vidyalaya Selection Test (JNVST) Result 2025 for Classes 6 and 9. Candidates who have appeared for the JNVST can check the ...

On Friday, Novartis AG (NYSE:NVS) released new data that confirm the long-term efficacy and safety of remibrutinib, a highly selective Bruton's tyrosine kinase (BTK) inhibitor, in chronic ...